23 Einträge gefunden

1. EBV and 1q Gains Affect Gene and miRNA Expression in Burkitt Lymphoma

   1. Akyüz, Nuray
   2. Janjetovic, Snjezana
   3. Ghandili, Susanne
   4. Bokemeyer, Carsten
   5. Dierlamm, Judith

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. NTRK fusion protein expression is absent in a large cohort of diffuse large B-cell lymphoma

   1. Ghandili, Susanne
   2. Dierlamm, Judith
   3. Bokemeyer, Carsten
   4. von Bargen, Clara Marie
   5. Weidemann, Sören Alexander

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
3. Non-Random Pattern of Integration for Epstein-Barr Virus with Preference for Gene-Poor Genomic Chromosomal Regions into the Genome of Burkitt Lymphoma Cell Lines

   1. Janjetovic, Snjezana
   2. Hinke, Juliane
   3. Balachandran, Saranya
   4. Akyüz, Nuray
   5. Behrmann, Petra
   6. Bokemeyer, Carsten
   7. Dierlamm, Judith

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial

   1. Borchmann, Peter
   2. Plütschow, Annette
   3. Kobe, Carsten
   4. Greil, Richard
   5. Meissner, Julia
   6. Topp, Max S
   7. Ostermann, Helmut

   2021 - Forschungsinformationssystem des UKE
5. Molecular- and cytogenetic characterization of the IGH associated t(1;14) in a nodal marginal zone B-cell lymphoma case

   1. Akyüz, Nuray
   2. Penas, Eva Maria Murga
   3. Janjetovic, Snjezana
   4. Loges, Sonja
   5. Bokemeyer, Carsten
   6. Dierlamm, Judith

   2021 - Forschungsinformationssystem des UKE
6. Outcome of a Real-World Patient Cohort with Secondary CNS Lymphoma Treated with High-Intensity Chemoimmunotherapy and Autologous Stem Cell Transplantation

   1. Thiele, Benjamin
   2. Binder, Mascha
   3. Schliffke, Simon
   4. Frenzel, Christian
   5. Dierlamm, Judith
   6. Wass, Maxi
   7. Weisel, Katja C

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
7. Bevacizumab in Aggressive Pituitary Adenomas - Experience with 3 Patients

   1. Osterhage, Katharina
   2. Rotermund, Roman
   3. Droste, Michael
   4. Dierlamm, Judith
   5. Saeger, Wolfgang
   6. Petersenn, Stephan
   7. Aberle, Jens

   2021 - Forschungsinformationssystem des UKE
8. Successful Treatment of Delayed Methotrexate Clearance using Glucarpidase Dosed on Ideal Body Weight in Obese Patients

   1. Krüger, Caroline
   2. Engel, Nils
   3. Reinert, Jochim
   4. Alsdorf, Winfried
   5. Fiedler, Walter
   6. Dierlamm, Judith
   7. Bokemeyer, Carsten

   2020 - Forschungsinformationssystem des UKE
9. Molecular profiling of an osseous metastasis in glioblastoma during checkpoint inhibition: potential mechanisms of immune escape

   1. Mohme, Malte
   2. Maire, Cecile L
   3. Schliffke, Simon
   4. Joosse, Simon A
   5. Alawi, Malik
   6. Matschke, Jakob
   7. Schüller, Ulrich

   2020 - Forschungsinformationssystem des UKE - frei zugänglich
10. Fulminant blast crisis with de novo 11q23 rearrangement in a Philadelphia-positive CML patient undergoing treatment with dasatinib

    1. Janjetovic, Snjezana
    2. Asemissen, Anne Marie
    3. Dicker, Frank
    4. Binder, Mascha
    5. Dierlamm, Judith
    6. Bokemeyer, Carsten
    7. Schafhausen, Philippe

    2019 - Forschungsinformationssystem des UKE
11. MALT1 sequencing analyses in marginal zone B-cell lymphomas reveal mutations in the translocated MALT1 allele in an IGH-MALT1-positive MALT lymphoma

    1. Akyüz, Nuray
    2. Albert-Konetzny, Nadine
    3. Pott, Christiane
    4. Callet-Bauchu, Evelyne
    5. Bokemeyer, Carsten
    6. Murga Penas, Eva Maria
    7. Dierlamm, Judith

    2017 - Forschungsinformationssystem des UKE
12. Frondoside A induces AIF-associated caspase-independent apoptosis in Burkitt lymphoma cells

    1. Dyshlovoy, Sergey A
    2. Rast, Stefanie
    3. Hauschild, Jessica
    4. Otte, Katharina
    5. Alsdorf, Winfried H
    6. Madanchi, Ramin
    7. Kalinin, Vladimir I

    2017 - Forschungsinformationssystem des UKE
13. Optimization of rituximab for the treatment of DLBCL:increasing the dose for elderly male patients

    1. Pfreundschuh, Michael
    2. Murawski, Niels
    3. Zeynalova, Samira
    4. Ziepert, Marita
    5. Loeffler, M
    6. Hänel, Matthias
    7. Dierlamm, Judith

    2017 - Forschungsinformationssystem des UKE
14. The beauty and the beast: lymphoma-like morphology of myeloid blast phase in CML

    1. Asemissen, Anne Marie
    2. Dierlamm, Judith

    2017 - Forschungsinformationssystem des UKE
15. Efficient transformation of primary human mesenchymal stromal cells by adenovirus early region 1 oncogenes

    1. Speiseder, Thomas
    2. Hofmann-Sieber, Helga
    3. Rodríguez, Estefanía
    4. Schellenberg, Anna
    5. Akyüz, Nuray
    6. Dierlamm, Judith
    7. Spruss, Thilo

    2016 - Forschungsinformationssystem des UKE
16. Severe and irreversible myelopathy after concurrent systemic and intrathecal nucleoside analogue treatment for refractory diffuse large B-cell lymphoma: A case report and review of the literature

    1. Alsdorf, Winfried H
    2. Schmitz, Michael
    3. Schieferdecker, Aneta
    4. Dierlamm, Judith
    5. Bokemeyer, Carsten
    6. Binder, Mascha

    2016 - Forschungsinformationssystem des UKE
17. Complementarity determining region-independent recognition of a superantigen by B-cell antigen receptors of mantle cell lymphoma

    1. Fichtner, Michael
    2. Spies, Elmar
    3. Seismann, Henning
    4. Riecken, Kristoffer
    5. Engels, Niklas
    6. Gösch, Barbara
    7. Dierlamm, Judith

    2016 - Forschungsinformationssystem des UKE
18. Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samples

    1. Murga-Penas, Eva-Maria
    2. Schilling, Georgia
    3. Behrmann, Petra
    4. Klokow, Marianne
    5. Vettorazzi, Eik
    6. Bokemeyer, Carsten
    7. Dierlamm, Judith

    2014 - Forschungsinformationssystem des UKE
19. Molecular characterization of chromosomal band 5p15.33: a recurrent breakpoint region in mantle cell lymphoma involving the TERT-CLPTM1L locus.

    1. Schilling, Georgia
    2. Murga-Penas, Eva-Maria
    3. Janjetovic, Snjezana
    4. Oliveira Ferrer, Leticia
    5. Balabanov, Melanie
    6. Behrmann, Petra
    7. Bokemeyer, Carsten

    2013 - Forschungsinformationssystem des UKE
20. Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cells.

    1. Brassat, Ute
    2. Balabanov, Stefan
    3. Bali, Daniel
    4. Dierlamm, Judith
    5. Balabanov, Melanie
    6. Hartmann, Ulrike
    7. Sirma, Hüseyin

    2011 - Forschungsinformationssystem des UKE